Find clinical trials for Non-Hodgkin Lymphoma in Roma, Lazio
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Hodgkin Lymphoma trials near Roma, Lazio, ITA:
and young adult participants with recurrent or refractory classical Hodgkin lymphoma and non-Hodgkin lymphoma...
Phase 1, Phase 2
Roma, Italy and 73 other locations
to Standard Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracyc...
Phase 3
Roma, RM, Italy and 66 other locations
This is a Phase 1/2 study of imvotamab in adult subjects with relapsed or refractory B-cell Non-Hodgkin Lymphoma. This stu...
Phase 1, Phase 2
Roma, RM, Italy and 26 other locations
ifosfamide, carboplatin, and etoposide (R-ICE) in pediatric and young adult participants with relapsed and refractory (R/R) mature B-cell non...
Phase 1, Phase 2
Roma, Lazio, Italy and 21 other locations
lymphoblastic leukemia (ALL) or relapsed or refractory (r/r) B-cell non-Hodgkin lymphoma (NHL).As of October 2022, no furt...
Phase 1, Phase 2
Rome, Italy and 36 other locations
according to the Lugano Classification of response in malignant lymphoma (Cheson, 2014) and as assessed by independent central review in eac-...
Phase 2
Terni, Italy and 137 other locations
The most common types of mature B-cell lymphomas (MBLs) in children are Burkitt lymphoma (BL) and diffuse large B-cell lymphoma...
Phase 1
Rome, Roma, Italy and 39 other locations
purpose of this study is to assess the objective response rate of parsaclisib treatment in participants with relapsed or refractory follicular lymphoma...
Phase 2
Rome, Italy and 82 other locations
in participants diagnosed with relapsed or refractory marginal zone lymphoma (MZL) who are naive to or were previously treated with a Bruton...
Phase 2
Rome, Italy and 85 other locations
regimens in participants with relapsed or refractory mantle cell lymphoma (MCL) previously treated either with or without a Bruton's tyrosin...
Phase 2
Rome, Italy and 102 other locations
Clinical trials
Research sites
Resources
Legal